135 related articles for article (PubMed ID: 38358191)
21. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
22. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
23. Hysteroscopic morphological pattern reflects histological grade of endometrial cancer.
Miyamoto T; Abiko K; Murakami R; Furutake Y; Baba T; Horie A; Hamanishi J; Mandai M
J Obstet Gynaecol Res; 2019 Aug; 45(8):1479-1487. PubMed ID: 31074203
[TBL] [Abstract][Full Text] [Related]
24. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
[TBL] [Abstract][Full Text] [Related]
25. Does Specimen Type Have an Impact on HER2 Status in Endometrial Serous Carcinoma? Discordant HER2 Status of Paired Endometrial Biopsy and Hysterectomy Specimens in the Presence of Frequent Intratumoral Heterogeneity.
Rottmann D; Assem H; Matsumoto N; Wong S; Hui P; Buza N
Int J Gynecol Pathol; 2021 May; 40(3):263-271. PubMed ID: 32897955
[TBL] [Abstract][Full Text] [Related]
26. Reliability of tumour grade 1 and endometrioid cell type on preoperative endometrial biopsy.
Baek MH; Park YR; Suh DS; Lee SW; Park JY; Kim D; Kim JH; Kim YM; Kim YT; Nam JH
J Obstet Gynaecol; 2015 Jan; 35(1):79-81. PubMed ID: 25093908
[TBL] [Abstract][Full Text] [Related]
27. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
[TBL] [Abstract][Full Text] [Related]
28. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.
Park JK; Otsuka N; Tomaru U; Suzuki H; Azuma M; Okamoto K; Yamashiro K; Kasahara M
Hum Pathol; 2018 Oct; 80():104-112. PubMed ID: 29936059
[TBL] [Abstract][Full Text] [Related]
31. Failure to recognize preoperatively high-risk endometrial carcinoma is associated with a poor outcome.
Di Cello A; Rania E; Zuccalà V; Venturella R; Mocciaro R; Zullo F; Morelli M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():153-60. PubMed ID: 26409060
[TBL] [Abstract][Full Text] [Related]
32. Prediction of histological types of endometrial cancer by endometrial cytology.
Okadome M; Saito T; Nishiyama N; Ariyoshi K; Shimamoto K; Shimada T; Kodama K; Imamura S; Nishiyama K; Taguchi K
J Obstet Gynaecol Res; 2014 Jul; 40(7):1931-9. PubMed ID: 25056473
[TBL] [Abstract][Full Text] [Related]
33. Morphometrical Differences among Endometrial Endometrioid Carcinoma Grade 1, Grade 3, and Serous Carcinoma in Endometrial Liquid-Based Cytology Preparations.
Odashima H; Yoshioka H; Minami K; Miyakawa K; Horie K; Norimatsu Y; Yanoh K; Watanabe J
Acta Cytol; 2022; 66(6):524-531. PubMed ID: 36096095
[TBL] [Abstract][Full Text] [Related]
34. Tumor Grade Correlation Between Preoperative Biopsy and Final Surgical Specimen in Endometrial Cancer: The Use of Different Diagnostic Methods and Analysis of Associated Factors.
Lago V; Martín B; Ballesteros E; Cárdenas-Rebollo JM; Minig L
Int J Gynecol Cancer; 2018 Sep; 28(7):1258-1263. PubMed ID: 29994910
[TBL] [Abstract][Full Text] [Related]
35. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.
Alwafai Z; Beck MH; Fazeli S; Gürtler K; Kunz C; Singhartinger J; Trojnarska D; Zocholl D; Krankenberg DJ; Blohmer JU; Sehouli J; Pietzner K
BMC Cancer; 2024 Mar; 24(1):380. PubMed ID: 38528468
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
[TBL] [Abstract][Full Text] [Related]
38. Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.
Ahmed QF; Gattoc L; Al-Wahab Z; Abdulfatah E; Ruterbusch JJ; Cote M; Bandyopadhyay S; Morris RT; Ali-Fehmi R
Am J Surg Pathol; 2015 Feb; 39(2):221-6. PubMed ID: 25517962
[TBL] [Abstract][Full Text] [Related]
39. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
40. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Alkushi A; Köbel M; Kalloger SE; Gilks CB
Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
